scispace - formally typeset
Journal ArticleDOI

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.

Reads0
Chats0
TLDR
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs) as discussed by the authors, which is considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs.
Abstract
The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs) LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs To date, more than 70 molecules have been identified in LBs, in which alpha-synuclein is a major constituent of LB fibrils Alpha-synuclein immunohistochemistry reveals that diffuse cytoplasmic staining develops into pale bodies via compaction, and that LBs arise from the peripheral portion of pale bodies This alpha-synuclein abnormality is found in 10% of pigmented neurons in the substantia nigra and more than 50% of those in the locus ceruleus in PD Recent studies have suggested that oligomers and protofibrils of alpha-synuclein are cytotoxic, and that LBs may represent a cytoprotective mechanism in PD

read more

Citations
More filters
Journal ArticleDOI

Oxidative stress in neurodegenerative diseases.

TL;DR: This review presents as much detailed information as possible that is available on various neurodegenerative disorders and their connection with oxidative stress to present a variety of therapeutic strategies designed to address these pathological processes.
Journal ArticleDOI

Mitochondrial Dysfunction in Parkinson's Disease

TL;DR: A considerable body of evidence linking mitochondrial dysfunction with neuronal cell death in the substantia nigra pars compacta of PD patients is illustrated and the important need for further research in this area is highlighted.
Journal ArticleDOI

Invited Article: Nervous system pathology in sporadic Parkinson disease

TL;DR: The Lewy body pathology associated with the synucleinopathy sporadic (or idiopathic) PD, the most widespread form of parkinsonism, is referred to.
Journal ArticleDOI

Complexity of dopamine metabolism

TL;DR: This review highlights different aspects of dopamine metabolism in the context of PD and neurodegeneration by looking at DA biosynthesis, sequestration, degradation and oxidation chemistry at the metabolic level, as well as at the transcriptional, translational and posttranslational regulation of all enzymes involved.
Journal ArticleDOI

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

TL;DR: If presynaptic α-synuclein aggregation, not neuronal loss, is the key issue of the neurodegenerative process, then PD and DLB may eventually be treatable in the future and stem cell transplants are of limited use.
References
More filters
Journal ArticleDOI

Staging of brain pathology related to sporadic Parkinson’s disease

TL;DR: This study traces the course of the pathology in incidental and symptomatic Parkinson cases proposing a staging procedure based upon the readily recognizable topographical extent of the lesions.
Journal ArticleDOI

Mutation in the α-synuclein gene identified in families with Parkinson's disease

TL;DR: A mutation was identified in the α-synuclein gene, which codes for a presynaptic protein thought to be involved in neuronal plasticity, in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype.
Journal ArticleDOI

Alpha-synuclein in Lewy bodies.

TL;DR: Strong staining of Lewy bodies from idiopathic Parkinson's disease with antibodies for α-synuclein, a presynaptic protein of unknown function which is mutated in some familial cases of the disease, indicates that the LewY bodies from these two diseases may have identical compositions.
Related Papers (5)